NASDAQ:TNDM
Tandem Diabetes Care Inc.
Tandem Diabetes Care Inc.'s revenue grew 7.9% in fiscal 2025 to $1.0B while operating margin fell to −18.5%. Free cash flow was −$29.7M, −2.9% of revenue, and the diluted share count rose 2.8%.Summary generated from Tandem Diabetes Care Inc.'s SEC filings. Latest annual report filed Feb 19, 2026.
Key statistics
Fiscal 2025 from SEC filings. MethodologyRevenue (FY25)$1.0B
Revenue growth+7.9%
Revenue, 5-yr CAGR+15.3%
Gross margin53.8%
Operating margin−18.5%
Net margin−20.2%
ROIC−32.3%
Return on equity−97.9%
Debt / equity2.00
Free cash flow−$29.7M
FCF margin−2.9%
Share count change+2.8%
Financials
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 703 | 801 | 748 | 940 | 1,015 |
| Operating income | 23 | −93 | −233 | −99 | −187 |
| Net income | 16 | −95 | −223 | −96 | −205 |
| Free cash flow | 97 | 16 | −59 | 5 | −30 |
Recent filings
- 4Insider transaction report
Aug 18, 2026 - 4Insider transaction report
Aug 18, 2026 - 10-QQuarterly report for the period ended Jun 30, 2026
Aug 6, 2026 - 8-KResults of operations and financial condition
Aug 6, 2026 - 8-KDirector or officer change
May 21, 2026 - 8-KDirector or officer change
May 15, 2026 - 10-QQuarterly report for the period ended Mar 31, 2026
May 7, 2026 - 8-KResults of operations and financial condition
May 7, 2026